Prostate Cancer: Translational and Emerging Therapies Book

Scientists have reached a critical point in the development of new therapies for prostate cancer. The information gleaned from the Human Genome Project, alongside the emergence of new technologies for the use of genetic data has expanded the physician's understanding of disease progression and widened his armamentarium for prostate cancer prevention and control. This expertly-written reference thoroughly analyzes the scientific principles and methodologies behind the most recent translational therapies and provides the necessary context, data, and studies for practitioners to select appropriate candidates for treatment and effectively apply new therapies in clinical practice.

Doody Review Services

Reviewer:Martin I Resnick, M.D.(University Hospitals of Cleveland)
Description:It is recognized that basic research activities often initiate clinical advances and this book provides up-to-date information on evolving therapies that translate into improved treatment for patients with prostate cancer. These topics are important and appropriate for physicians treating these patients.
Purpose:The purpose of the book is to demonstrate how basic research activities are relevant to clinical practice and how work at the bench can be translated to the patient's bedside. It is becoming increasingly recognized that research directed in this manner is most important and has been successful in benefiting patients. This book clearly shows how this process occurs.
Audience:It is written for researchers and clinicians interested in prostate cancer. The topics reviewed are being investigated by many and the book should be of interest to these individuals. The editors and chapter authors are recognized authorities and have appropriately addressed their assigned topics.
Features:The book addresses factors resulting in the etiology of prostate cancer, its growth and various therapies. Many in the latter category remain at the bench, but their evolution to the bedside is not far away. These offer much promise for patients with aggressive and/or advanced disease. The concept of basic research evolving to the clinical arena is not new, but this book specifically targets this concept at prostate cancer — a common and important disease affecting men worldwide.
Assessment:This is a new book addressing the important concept ofbench research evolving to the bedside. It is increasingly recognized that efforts in this manner are needed to advance clinical care. The book should be of interest to those interested in research activities and in clinical care of men with prostate cancer.